
10X Genomics (TXG) P/E Ratio
P/E Ratio as of Jun 13, 2025: -8.04
Average-7.24
Median-7.21
Minimum-8.32
Maximum-6.31
-8.04
Past Month-1.00 (14.20%)
The P/E ratio for 10X Genomics (TXG) is -8.04 as of Jun 13, 2025. This represents a decrease of -11.75% compared to its 12-month average P/E ratio of -9.11. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
10X Genomics P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
10X Genomics’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing 10X Genomics to industry peers.
10X Genomics P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
10X Genomics’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing 10X Genomics to industry peers.
10X Genomics (TXG) P/E Ratio Insights
See 10X Genomics’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in 10X Genomics (TXG)
Order type
Buy in
Order amount
Est. shares
0 shares
10X Genomics (TXG) P/E Ratio Historic Data
Date | Stock price | P/E ratio |
---|---|---|
Jun 2, 2025 | $9.45 | -7.30 |
May 1, 2025 | $8.10 | -5.34 |
Apr 1, 2025 | $8.67 | -5.71 |
Mar 3, 2025 | $9.85 | -6.49 |
Feb 3, 2025 | $14.45 | -9.46 |
Jan 2, 2025 | $14.19 | -9.29 |
10X Genomics (TXG) End of Year P/E Ratio
Date | P/E ratio | Change |
---|---|---|
2025 | -8.04 | -14.56% |
2024 | -9.41 | -67.82% |
2023 | -29.24 | +18.38% |
2022 | -24.70 | -91.27% |
2021 | -282.87 | +927.50% |
2020 | -27.53 | — |
FAQs About 10X Genomics (TXG) P/E ratio
The latest P/E ratio of 10X Genomics (TXG) is -8.04, as of Jun 13, 2025. This is calculated based on its current stock price and earnings per share (EPS).
10X Genomics’s last 12-month average P/E ratio is -9.11, compared to its current P/E ratio of -8.04. This reflects a decrease of -11.75%.
10X Genomics’s current P/E ratio of -8.04 is lower than its last 12-month average P/E of -9.11. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
10X Genomics’s average P/E ratio over the last 3 years is -20.71. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
10X Genomics’s average P/E ratio over the last 5 years is -45.04. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.